Cidara Therapeutics Inc (CDTX) stock news · $6.96B cap
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
This CDTX news page leads with what Cidara Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CDTX yet. We will not pad this page with generic market recap.
Latest reported CDTX revenue for 2025-09-30 was $0. Net income was -$83.2M. CDTX currently screens at market cap $6.96B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CDTX stock page; for the tape open the quote page.
CDTX stock news FAQ
What is CDTX's latest net income?
Latest cached Cidara Therapeutics Inc (CDTX) net income was -$83.2M. Statements: https://lician.com/financials/cdtx
What is CDTX's market cap?
Cidara Therapeutics Inc (CDTX) market cap is $6.96B on the latest cached fundamentals snapshot.
What kind of company is CDTX?
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Where is CDTX stock news listed?
Cached stock news for Cidara Therapeutics Inc (CDTX) is listed at https://lician.com/news/cdtx. Filings: https://lician.com/sec/cdtx
Not investment advice.